Does Rallies show 13F holders for IRTC?

Yes. Rallies tracks hedge fund and 13F ownership data for IRTC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is IRTC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IRTC. It does not provide personalized investment advice.

IRTC (iRhythm Holdings, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

iRhythm Holdings, Inc. Common Stock (IRTC) is a publicly traded Healthcare sector company. As of May 21, 2026, IRTC trades at $117.00 with a market cap of $3.65B and a P/E ratio of -83.62. IRTC moved +2.80% today. Year to date, IRTC is -36.55%; over the trailing twelve months it is -17.14%. Its 52-week range spans $55.92 to $212.00. Analyst consensus is strong buy with an average price target of $184.00. Rallies surfaces IRTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns IRTC stock?

Hedge funds tracked by Rallies that own IRTC include Redmile Group and Bridgewater Associates. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for iRhythm Holdings, Inc. Common Stock.

IRTC Key Metrics

Key financial metrics for IRTC
Metric	Value
Price	$117.00
Market Cap	$3.65B
P/E Ratio	-83.62
EPS	$-1.39
Dividend Yield	0.00%
52-Week High	$212.00
52-Week Low	$55.92
Volume	0
Avg Volume	0
Revenue (TTM)	$747.14M
Net Income	$-44.55M
Gross Margin	70.57%

Top Hedge Funds Holding IRTC

Redmile Group holds 56.84K shares of IRTC, changed +0.00% as of Mar 31, 2025.
Bridgewater Associates holds 11.35K shares of IRTC, changed +237.34% as of Dec 31, 2025.

Latest IRTC News

iRhythm Q1 Revenue Jumps 25.7% to $199.4M; Full-Year Guidance Upgraded — Apr 30, 2026
iRhythm Data Shows 26% Post-Ablation AF Recurrences, 60% Pregnancy Arrhythmias Detected After 48 Hours — Apr 27, 2026
iRhythm launches Academy, shows 48% arrhythmia in CKD and 2.8x AF risk — Mar 30, 2026
iRhythm Appoints UnitedHealth Enterprise Strategy EVP Jason Patten to Board — Mar 12, 2026
iRhythm Reports Q4 Revenue Up 27.1% to $208.9M, First GAAP Profit — Mar 2, 2026

Recent IRTC Insider Trades

TALWALKAR ABHIJIT Y bought 5.31K (~$56.89K) on May 11, 2026.
TALWALKAR ABHIJIT Y sold 940 (~$109.09K) on May 11, 2026.
TALWALKAR ABHIJIT Y sold 642 (~$75.10K) on May 11, 2026.

IRTC Analyst Consensus

13 analysts cover IRTC: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $184.00.

Common questions about IRTC

Who owns IRTC stock?: Hedge funds tracked by Rallies that own IRTC include Redmile Group and Bridgewater Associates. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for iRhythm Holdings, Inc. Common Stock.
Does Rallies show 13F holders for IRTC?: Yes. Rallies tracks hedge fund and 13F ownership data for IRTC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IRTC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IRTC. It does not provide personalized investment advice.